Development of medications to treat cocaine abuse is an important goal. In order to develop new drugs which prevent binding of cocaine to its target, the dopamine transporter (DAT), it would be very useful to know where both cocaine and dopamine bind on the transporter protein. One approach to localization of the binding site for cocaine has been to explore the structural features which affect binding to the transporter. An extension of this approach has been to develop inhibitors which bind irreversibly to the transporter. This class of compounds reacts with the protein to form a covalent bond between the inhibitor and the protein. The objective then is to identify the site of covalent attachment. This is done by cleavage of the protein and following the protein fragment to which the ligand remains attached. Work by investigators at NIDA have used this method to begin to localize two photoaffinity ligands, [125I]RTI-82, a cocaine analog, and [125I]DEEP, a GBR analog to different domains of DAT. The proposed work is designed to use mass spectrometry to identify the sites of attachment of these ligands within the previously identified DAT fragments. In addition, the sites of attachment of two new photoaffinity ligands, which are substrates for DAT, will also be identified. The combined results will help to construct a picture of the ligand binding regions critical for DAT function and inhibition.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011176-03
Application #
2898156
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Pilotte, Nancy S
Project Start
1997-08-20
Project End
2000-07-31
Budget Start
1999-08-23
Budget End
2000-07-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Emory University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Lever, John R; Zou, Mu-Fa; Parnas, M Laura et al. (2005) Radioiodinated azide and isothiocyanate derivatives of cocaine for irreversible labeling of dopamine transporters: synthesis and covalent binding studies. Bioconjug Chem 16:644-9
Vaughan, Roxanne A; Parnas, M Laura; Gaffaney, Jon D et al. (2005) Affinity labeling the dopamine transporter ligand binding site. J Neurosci Methods 143:33-40
Cao, Jianjing; Lever, John R; Kopajtic, Theresa et al. (2004) Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter. J Med Chem 47:6128-36
Reed, Brian; Chen, Nianhang; Justice Jr, Joseph B (2003) Dual-electrode voltammetry of catecholamine transport: simultaneous monitoring of uptake and efflux. J Neurosci Methods 126:127-35
Whitehead, R E; Ferrer, J V; Javitch, J A et al. (2001) Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J Neurochem 76:1242-51
Zou, M F; Kopajtic, T; Katz, J L et al. (2001) Novel tropane-based irreversible ligands for the dopamine transporter. J Med Chem 44:4453-61
Chen, N; Justice, J B (2000) Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine. Brain Res Mol Brain Res 75:208-15
Thompson, A C; Zapata, A; Justice Jr, J B et al. (2000) Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci 20:9333-40